What is Stephen H. Lockhart’s direct share ownership in NRC (NRC) after the grant?

After the equity grant, Stephen H. Lockhart directly holds 7,697 shares of NRC Health common stock. This figure reflects his total direct holdings immediately following the reported award, as shown in the Form 4 transaction details.

NRC Health (NRC) director awarded 7,697 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.

NRC Health director Stephen H. Lockhart reported receiving an equity grant of 7,697 shares of common stock as annual compensation. According to the disclosure, this grant represents restricted stock units valued at $150,000, determined using the closing share price before the company’s 2026 annual stockholders meeting.

The award was granted under NRC Health’s 2025 Omnibus Incentive Plan and will vest and become exercisable on the date of the company’s 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination provisions. Following this award, Lockhart directly holds 7,697 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lockhart Stephen H

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,697	$0.00	--

Holdings After Transaction: Common Stock — 7,697 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Equity award shares: 7,697 shares Award value: $150,000 Shares held after grant: 7,697 shares +1 more

4 metrics

Equity award shares 7,697 shares Grant of common stock / RSUs as annual equity compensation

Award value $150,000 Equity grant value divided by closing price before 2026 annual meeting

Shares held after grant 7,697 shares Total direct ownership following reported Form 4 transaction

Vesting date 2027 annual stockholder meeting Restricted stock unit award vests and becomes exercisable on this date

Key Terms

restricted stock units, 2025 Omnibus Incentive Plan, annual equity compensation

3 terms

restricted stock units financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Incentive Plan financial

"under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

annual equity compensation financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 04:41 PM Accepted by SEC EDGAR 06/25/2026 - 04:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lockhart Stephen H

(Last)

(First)

(Middle)

C/O NRC HEALTH

1245 Q STREET

(Street)

LINCOLN

NEBRASKA

68508

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NRC HEALTH [ NRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/23/2026		A		7,697⁽¹⁾	A⁽¹⁾	$0	7,697	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

	/s/ Stephen H. Lockhart, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did NRC (NRC) report for Stephen H. Lockhart?

NRC Health reported that director Stephen H. Lockhart received a grant of 7,697 common shares as annual equity compensation. The grant is in the form of restricted stock units under the company’s 2025 Omnibus Incentive Plan, with vesting tied to the 2027 annual stockholder meeting.

How was the value of Stephen H. Lockhart’s NRC (NRC) equity award determined?

The equity award for Stephen H. Lockhart was set at $150,000 and converted into restricted stock units using the closing share price on the trading day before NRC Health’s 2026 annual stockholders meeting. This calculation produced the 7,697-unit grant disclosed in the Form 4 filing.

When do Stephen H. Lockhart’s NRC (NRC) restricted stock units vest?

Stephen H. Lockhart’s restricted stock units are scheduled to vest and become exercisable on the date of NRC Health’s 2027 annual stockholder meeting. Vesting remains subject to the award’s stated vesting, forfeiture, and termination provisions, as outlined in the company’s 2025 Omnibus Incentive Plan.

Does NRC (NRC) indicate that Stephen H. Lockhart bought shares in the market?

The filing shows no open-market purchase by Stephen H. Lockhart. Instead, he received 7,697 common shares as a compensation-related grant at no cash cost per share, classified as a grant or award acquisition rather than a market transaction.